MP:0000150 | abnormal rib morphology | "malformed bones forming the bony wall of the chest" [Stedman s Medical Dictionary , 27th edition:ISBN 0-683-40008-8, J:50311] |
Show
Allelic Composition: Prkab1tm1b(KOMP)Wtsi/Prkab1tm1b(KOMP)Wtsi Genetic Background: C57BL/6N-Prkab1tm1b(KOMP)Wtsi/Ieg
|
MP:0000747 | muscle weakness | "loss of muscle strength" [csmith:Cynthia L. Smith, Mouse Genome Informatics Curator] |
Show
Allelic Composition: EdarDl-slk/Edar+ Genetic Background: Not Specified
|
MP:0000759 | abnormal skeletal muscle morphology | "anomalous structure of any of the striated muscle fibers connected at either or both extremeties with the bony framework of the body" [Stedman s Medical Dictionary:ISBN 0-683-40008-8] |
Show
Allelic Composition: Egr2tm2(cre)Pch/Egr2+,Phox2btm4Jbr/Phox2b+ Genetic Background: involves: 129S2/SvPas * C57BL/6 * DBA/2
|
MP:0001402 | hypoactivity | "reduced movement from one place to another" [Stedman s Medical Dictionary , 27th edition:ISBN 0-683-40008-8, csmith:Cynthia L. Smith , Mouse Genome Informatics Curator, J:64289] |
Show
Allelic Composition: Egr2tm2(cre)Pch/Egr2+,Phox2btm4Jbr/Phox2b+ Genetic Background: involves: 129S2/SvPas * C57BL/6 * DBA/2
|
MP:0001552 | increased circulating triglyceride level | "higher than normal concentration of triacylglycerols in the blood" [Stedman s Medical Dictionary , 27th edition:ISBN 0-683-40008-8, J:65416] |
Show
Allelic Composition: Prkab2Gt(AL0483)Wtsi/Prkab2Gt(AL0483)Wtsi Genetic Background: B6.129P2-Prkab2Gt(AL0483)Wtsi
|
MP:0002078 | abnormal glucose homeostasis | "anomaly in the state of equilibrium or processing in the body with respect to glucose in the fluids and tissues" [csmith:Cynthia L. Smith , Mouse Genome Informatics Curator] |
Show
Allelic Composition: EdarDl-slk/Edar+ Genetic Background: Not Specified
|
MP:0002079 | increased circulating insulin level | "greater than normal levels of insulin in blood" [Stedman s Medical Dictionary , 27th edition:ISBN 0-683-40008-8] |
Show
Allelic Composition: EdarDl-slk/Edar+ Genetic Background: Not Specified
Allelic Composition: Prkab2Gt(AL0483)Wtsi/Prkab2Gt(AL0483)Wtsi Genetic Background: B6.129P2-Prkab2Gt(AL0483)Wtsi
|
MP:0002118 | abnormal lipid homeostasis | "anomaly in the state of equilibrium in the body with respect to lipids in the fluids and tissues" [csmith:Cynthia L. Smith , Mouse Genome Informatics Curator] |
Show
Allelic Composition: EdarDl-slk/Edar+ Genetic Background: Not Specified
|
MP:0002715 | reduced glycogen catabolism rate | "decreased breakdown of this highly branched polysaccharide composed of glucose subunits; glycogen is the major carbohydrate storage form in the body " [cwg:Carroll-Ann W. Goldsmith , Mouse Genome Informatics curator] |
Show
Allelic Composition: Prkab2Gt(AL0483)Wtsi/Prkab2Gt(AL0483)Wtsi Genetic Background: B6.129P2-Prkab2Gt(AL0483)Wtsi
|
MP:0003646 | muscle fatigue | "increased muscle exhaustion or increased susceptibility to muscle exhaustion" [J:96306] |
Show
Allelic Composition: Egr2tm2(cre)Pch/Egr2+,Phox2btm4Jbr/Phox2b+ Genetic Background: involves: 129S2/SvPas * C57BL/6 * DBA/2
|
MP:0005293 | impaired glucose tolerance | "less than the normal response to oral consumption or intravenous injection of specified amounts of glucose and indicative of insulin resistance; measured by determining whole blood or plasma sugar level in a fasting state before and after taking glucose at specified intervals" [MeSH:National Library of Medicine - Medical Subject Headings , 2003] |
Show
Allelic Composition: Prkab2Gt(AL0483)Wtsi/Prkab2Gt(AL0483)Wtsi Genetic Background: B6.129P2-Prkab2Gt(AL0483)Wtsi
|
MP:0005331 | insulin resistance | "diminished effectiveness of insulin in lowering plasma glucose levels" [Stedman s Medical Dictionary:ISBN 0-683-40008-8, J:84260, pvb:Pierre Vanden Borre , Mouse Genome Informatics Curator] |
Show
Allelic Composition: EdarDl-slk/Edar+ Genetic Background: Not Specified
Allelic Composition: Prkab2Gt(AL0483)Wtsi/Prkab2Gt(AL0483)Wtsi Genetic Background: B6.129P2-Prkab2Gt(AL0483)Wtsi
|
MP:0005559 | increased circulating glucose level | "greater than the normal concentration in the blood of this major monosaccharide of the body; it is an important energy source" [cwg:Carroll-Ann W. Goldsmith , Mouse Genome Informatics curator, RGD:Rat Genome Database submission] |
Show
Allelic Composition: Egr2tm2(cre)Pch/Egr2+,Phox2btm4Jbr/Phox2b+ Genetic Background: involves: 129S2/SvPas * C57BL/6 * DBA/2
|
MP:0005560 | decreased circulating glucose level | "less than the normal concentration in the blood of this major monosaccharide of the body; it is an important energy source" [RGD:Rat Genome Database submission, cwg:Carroll-Ann W. Goldsmith , Mouse Genome Informatics curator] |
Show
Allelic Composition: Prkab2Gt(AL0483)Wtsi/Prkab2Gt(AL0483)Wtsi Genetic Background: B6.129P2-Prkab2Gt(AL0483)Wtsi
|
MP:0005584 | abnormal enzyme/coenzyme activity | "altered ability of any of these proteins, or their cofactors, to act as catalysts to induce chemical changes in other substances" [Stedman s Medical Dictionary:ISBN 0-683-40008-8] |
Show
Allelic Composition: Egr2tm2(cre)Pch/Egr2+,Phox2btm4Jbr/Phox2b+ Genetic Background: involves: 129S2/SvPas * C57BL/6 * DBA/2
|
MP:0005658 | susceptibility to diet-induced obesity | "more likely to become excessively fat or to increase fat in the subcutaneous connective tissue as a result of consuming a diet geared to increase body fat " [cwg:Carroll-Ann W. Goldsmith, Mouse Genome Informatics curator] |
Show
Allelic Composition: EdarDl-slk/Edar+ Genetic Background: Not Specified
|
MP:0008874 | decreased sensitivity to xenobiotics | "increase in the dose or concentration of a foreign compound required to induce a specific level of response" [MGI:smb "Susan M. Bello, Mouse Genome Informatics Curator"] |
Show
Allelic Composition: EdarDl-slk/Edar+ Genetic Background: Not Specified
|
MP:0009400 | decreased skeletal muscle fiber size | "decrease in the size of the large multinucleated cells that make up the skeletal muscles" [MGI:smb "Susan M. Bello, Mouse Genome Informatics Curator"] |
Show
Allelic Composition: EdarDl-slk/Edar+ Genetic Background: Not Specified
|
MP:0010024 | increased total body fat amount | "greater than the normal total amount of connective tissue composed of fat cells within the entire body" [MGI:csmith "Cynthia L. Smith, Mouse Genome Informatics Curator"] |
Show
Allelic Composition: Prkab2Gt(AL0483)Wtsi/Prkab2Gt(AL0483)Wtsi Genetic Background: B6.129P2-Prkab2Gt(AL0483)Wtsi
|
MP:0010398 | decreased liver glycogen level | "less than the normal concentration of a readily converted carbohydrate reserve in liver" [MGI:csmith "Cynthia L. Smith, Mouse Genome Informatics Curator"] |
Show
Allelic Composition: EdarDl-slk/Edar+ Genetic Background: Not Specified
|
MP:0010399 | decreased skeletal muscle glycogen level | "less than the normal concentration of a readily converted carbohydrate reserve in skeletal muscle" [MGI:csmith "Cynthia L. Smith, Mouse Genome Informatics Curator"] |
Show
Allelic Composition: EdarDl-slk/Edar+ Genetic Background: Not Specified
Allelic Composition: Prkab2Gt(AL0483)Wtsi/Prkab2Gt(AL0483)Wtsi Genetic Background: B6.129P2-Prkab2Gt(AL0483)Wtsi
|
MP:0011110 | partial preweaning lethality | "the appearance of lower than Mendelian ratios of organisms of a given genotype due to death of some, but not all of the organisms between fertilization and weaning age (Mus: approximately 3-4 weeks of age)" [MGI:csmith] |
Show
Allelic Composition: Prkab1tm1b(KOMP)Wtsi/Prkab1tm1b(KOMP)Wtsi Genetic Background: C57BL/6N-Prkab1tm1b(KOMP)Wtsi/Ieg
|
MP:0011400 | complete lethality | "all individuals of a given genotype in a population die before the end of the normal lifespan but time(s) of death are unspecified" [MGI:llw2] |
Show
Allelic Composition: Egr2tm2(cre)Pch/Egr2+,Phox2btm4Jbr/Phox2b+ Genetic Background: involves: 129S2/SvPas * C57BL/6 * DBA/2
|
MP:0012106 | impaired exercise endurance | "impaired performance during controlled physical activity" [MGI:smb] |
Show
Allelic Composition: EdarDl-slk/Edar+ Genetic Background: Not Specified
Allelic Composition: Prkab1tm1Grst/Prkab1tm1Grst,Prkab2tm1Grst/Prkab2tm1Grst,Tg(Ckmm-cre)5Khn/0 Genetic Background: involves: C57BL/6 * FVB
Allelic Composition: Prkab2tm1Grst/Prkab2tm1Grst,Tg(Ckmm-cre)5Khn/0 Genetic Background: involves: C57BL/6 * FVB
Allelic Composition: Prkab2Gt(AL0483)Wtsi/Prkab2Gt(AL0483)Wtsi Genetic Background: B6.129P2-Prkab2Gt(AL0483)Wtsi
|
MP:0030021 | increased muscle cell glucose uptake | "increased ability of muscle cells to take in glucose" [MGI:anna] |
Show
Allelic Composition: EdarDl-slk/Edar+ Genetic Background: Not Specified
|
MP:0030022 | decreased muscle cell glucose uptake | "reduced ability of muscle cells to take in glucose" [MGI:anna] |
Show
Allelic Composition: EdarDl-slk/Edar+ Genetic Background: Not Specified
Allelic Composition: Prkab1tm1Grst/Prkab1tm1Grst,Prkab2tm1Grst/Prkab2tm1Grst,Tg(Ckmm-cre)5Khn/0 Genetic Background: involves: C57BL/6 * FVB
Allelic Composition: Prkab2Gt(AL0483)Wtsi/Prkab2Gt(AL0483)Wtsi Genetic Background: B6.129P2-Prkab2Gt(AL0483)Wtsi
|